<DOC>
	<DOCNO>NCT01956786</DOCNO>
	<brief_summary>To evaluate efficacy Amlodipine-Folic Acid Tablets reduction blood pressure plasma total homocysteine .</brief_summary>
	<brief_title>Efficacy Amlodipine-Folic Acid Tablets Reduction Blood Pressure Plasma Homocysteine</brief_title>
	<detailed_description>Traditional risk factor estimate account part cardiovascular disease ( CVD ) risk . Non-traditional risk factor increase homocysteine concentration believe causally related CVD . The interactive effect hypertension hyperhomocysteinemia risk CVD receive great attention . Methylenetetrahydrofolate reductase ( MTHFR ) main regulatory enzyme homocysteine metabolism . MTHFR convert 5,10-methylene-THF 5-methyl-THF . Polymorphism MTHFR C677T lead reduction enzyme activity , may lead increased concentration plasma homocysteine low level serum folate , particularly low folate intake . Enalapril Maleate-Folate Tablets , know reduce blood pressure serum homocysteine thereby prevent stroke , find adverse event , cough , call ACEI-intolerance patient . In present study , seek ass : ( 1 ) efficacy safety Amlodipine-Folic Acid Tablets low blood pressure homocysteine patient mild moderate hypertension , hyperhomocysteinemia ( hcy≥10μmol/L ) ACEI intolerance ; ( 2 ) whether blood pressure homocysteine-lowing efficacy Amlodipine-Folic Acid Tablets modify individual MTHFR C677T polymorphism . In , 540 patient mild moderate hypertension , hyperhomocysteinemia ACEI intolerance enrol trial . Eligible subject randomly double-blindly assigned one three treatment groups:1 ) amlodipine tablet ( 5mg , control group ) ; 2 ) amlodipine-folic acid tablet ( 5mg amlodipine combine 0.4mg folic acid , low FA group ) ; 3 ) amlodipine-folic acid tablet ( 5mg amlodipine combine 0.8mg folic acid , high FA group ) , daily 8 week . The allocation participant program independent statistical coordinating center , encrypt , send study center.Tablet container label name trial allocate concealment number.The participant , care partner , staff directly involve trial blind intervention period trial . Demographic clinical information obtain baseline . Blood pressure examine baseline every two week total period 8 week . Blood homocysteine folate concentration examine baseline 4th、8th week trial . MTHFR C677T genotype determine study subject . All analysis perform accord principle intention treat .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Aged 1875 year ; 2 . Sedentary systolic blood pressure 140 mmHg 180 mmHg , and/or sedentary diastolic blood pressure 90 mmHg 110 mmHg ; 3 . Plasma homocysteine ≥ 10μmol/L ; 4 . ACEIintolerance 5 . Signed write informed consent . 1 . Pregnant woman woman within lactation period ; 2 . Hypersensitive Calcium Channel Blocker ( CCB ) folic acid ; 3 . Easily hypersensitiveness ; 4 . Diagnosed secondary hypertension skeptical secondary hypertension ; 5 . Severe hypertension ( sedentary systolic blood pressure great equal 180 mmHg and/or sedentary diastolic blood pressure great equal 110 mmHg ) 6 . Severe disease : 1 . Cardiovascular system : Diagnosed cardia insufficiency ( New York Health Association [ NYHA ] Ⅲ level high ) ; Hypertrophic obstructive cardiomyopathy ( HOCM ) ; Clinical significantly Valvular Disease Heart ( VDH ) ; Acute coronary syndrome coronary artery interventional therapy coronary artery bypass graft within three month ; Severe arrhythmia atrial flutter , atrial fibrillation , atrioventricular block Ⅱlevel , et al ; 2 . Alimentary system : Active virus hepatitis ; Any alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , galactosylhydroxylysyl glucosyltransferase ( GGT ) , alkaline phosphatase ( ALP ) , total bilirubin ( TBIL ) , Direct Bilirubin ( DB ) 2 time 's normal value upper limit , albumin ( ALB ) great 30 g/L ; Stomach bulk resect gastrojejunostomy ; Stomach intestine malabsorption ; 3 . Urinary system : Serum creatinine great equal 200 mmol/L ; Diagnosed stenosis renal artery , solitary kidney ; Renal transplantation ; 4 . Endocrine system : Type 1 diabetes mellitus uncontrolled type 2 diabetes mellitus ( fast glucose great equal 11.1 mmol/L ) ; Diagnosed uncontrolled hyperthyrosis ; 5 . Respiratory system : Pulmonary Heart Disease ; Chronic Obstructive Pulmonary Disease ( COPD ) ; 6 . Neuropsychiatric system : Transient Ischemia Attach ( TIA ) stroke within 3 month ; Severe peripheral nerve vegetative nerve functional disturbance ; Psyche nervous system dysfunction ; Drugs alcohol dependence ; 7 . Others : Malignant tumor , malnutrition , haematogenesis dysfunction , et al ; 7 . Obviously abnormal laboratory examination sign ; 8 . Taking antihypertensive drug unwilling stop ; 9 . Taking folic acid Vitamin B group unwilling stop ; 10 . Ever participant drug trial yet approve within 4 week first visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Amlodipine</keyword>
	<keyword>Folic Acid</keyword>
	<keyword>Homocysteine</keyword>
	<keyword>Blood Pressure</keyword>
</DOC>